Llwytho...

A New Mechanism of Action in Heart Failure: Angiotensin-Receptor Neprilysin Inhibition

Objective: To evaluate the efficacy, safety, and clinical significance of sacubitril/valsartan (Entresto) in patients with heart failure with a reduced ejection fraction (HFrEF). Data Sources: An extensive search was conducted on Ovid MEDLINE using keywords and medical subject headings LCZ696, sacub...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Pharm Technol
Prif Awduron: Richardson, Jonathan, David, Tosin, Grace, Yasmin, Guirguis, Erenie
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: SAGE Publications 2015
Pynciau:
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5998462/
https://ncbi.nlm.nih.gov/pubmed/34860952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/8755122515622224
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!